Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

Authors
Publication date
1 January 2019
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      DIAL UCLouvain

      redirect
      oaioai:dial.uclouvain.be:boreal:2...
      Last time updated on 12/02/2019